NCT03766230

Brief Summary

The degree of perceived pain in the second-eye surgery of cataract patients is significantly higher than that in the first-eye surgery, which can lead to nervous tension during surgery and affect the surgical outcome and satisfaction. Study suggested that in addition to psychological factors, there might be subclinical sympathetic reactions leading to increased pain in the second-eyes, but the objective indicators and clinical relevance are not clear. Therefore, it is necessary to study the mechanism of second-eye pain in cataract surgery, and to provide a test index that can effectively predict the degree of intraoperative pain in patients, as an important reference for the development of a suitable time for second eye surgery. This study is based on clinical case studies, recruiting patients with clinically diagnosed binocular age-related cataract and require binocular surgery, to compare the correlation of intraocular inflammatory factors in the second eye and patients' self-pain scores while both eyes' surgery are completed by the same doctor in the same operating room, and the correlation of the change of inflammatory factors and the time interval between the two eyes surgery, to analyze the second-eye subclinical sympathetic reaction changing with the time interval after the first cataract surgery from the molecular biological results. Using the latest international anterior segment vascularization optical coherence tomography(OCT) scan and optical microvascular imaging(OMAG) analysis technology to quantify iris blood flow, this study analyzes the iris blood flow density, vascular density and other indicators before and after cataract surgery, and carry out its correlation with the degree of intraocular subclinical sympathetic reaction, providing a rapid, non-invasive objective examination index of the second-eye subclinical sympathetic response.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2018

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 6, 2018

Completed
24 days until next milestone

Study Start

First participant enrolled

December 30, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2021

Completed
Last Updated

December 6, 2018

Status Verified

November 1, 2018

Enrollment Period

2.7 years

First QC Date

August 19, 2018

Last Update Submit

December 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Surgery Pain Severity Score

    visual analogue scale is used to assess the surgery pain. Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients. A VAS is usually a 100-mm long horizontal line with verbal descriptors (word anchors) at each end to express the extremes of the feeling, the position of the respondent's cross is generally assigned a score between 0 and 100.

    Within one hour after first eye surgery; within one hour after second eye surgery (performed up to 90 days after first eye surgery)

Secondary Outcomes (3)

  • Change in Concentration of inflammatory factors in aqueous humor

    aqueous humor is acquired at the beginning of the first eye surgery and the second eye surgery (performed up to 90 days after first eye surgery)

  • Change in blood flow density of iris vascular

    Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery)

  • Change in vascular density of iris vascular

    Within 24 hours before first eye surgery and Day 1, Week 1, Week 3, Month 1, Month 3 after first eye surgery, or within 24 hours before second-eye surgery (performed up to 90 days after first eye surgery)

Study Arms (10)

peribulbar anesthesia1

Time interval between two eyes' cataract surgery is or less than 14 days and using peribulbar anesthesia

topical anesthesia1

Time interval between two eyes' cataract surgery is or less than 14 days and using topical anesthesia

peribulbar anesthesia2

Time interval between two eyes' cataract surgery is from 15 to 21 days and using peribulbar anesthesia

topical anesthesia2

Time interval between two eyes' cataract surgery is from 15 to 21 days and using topical anesthesia

peribulbar anesthesia3

Time interval between two eyes' cataract surgery is from 22 to 28 days and using peribulbar anesthesia

topical anesthesia3

Time interval between two eyes' cataract surgery is from 22 to 28 days and using topical anesthesia

peribulbar anesthesia4

Time interval between two eyes' cataract surgery is from 29 to 60 days and using peribulbar anesthesia

topical anesthesia4

Time interval between two eyes' cataract surgery is from 29 to 60 days and using topical anesthesia

peribulbar anesthesia5

Time interval between two eyes' cataract surgery is from 61 to 90 days and using peribulbar anesthesia

topical anesthesia5

Time interval between two eyes' cataract surgery is from 61 to 90 days and using topical anesthesia

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Binocular senile cataract patients with binocular phacoemulsification and intraocular lens implantation to be performed at the Department of Ophthalmology in Shanghai Eye Disease Prevention and Treatment Center or Shanghai General Hospital from August 2018 to August 2020.

You may qualify if:

  • diagnosed with binocular age-related cataract.
  • Both eyes require phacoemulsification and intraocular lens implantation.
  • binocular surgery was performed by the same physician in the same operating room, and the anesthesia and surgical procedures were consistent.
  • Patients can fully understand the research purpose, research content, accidents and benefits and risks of the clinical trial, and can make their own decisions on participating or not.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

The aqueous humor will be obtained in the surgery and kept in centrifugal tube. The amount of inflammatory cytokines will be measured afterwards.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2018

First Posted

December 6, 2018

Study Start

December 30, 2018

Primary Completion

August 30, 2021

Study Completion

October 30, 2021

Last Updated

December 6, 2018

Record last verified: 2018-11